<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HD190F315B3624D69A8B0BE4CACDCB105" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2511 IH: Sarah Katz Caffeine Safety Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-31</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2511</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250331">March 31, 2025</action-date><action-desc><sponsor name-id="M001226">Mr. Menendez</sponsor> (for himself, <cosponsor name-id="S000522">Mr. Smith of New Jersey</cosponsor>, <cosponsor name-id="S001216">Ms. Schrier</cosponsor>, <cosponsor name-id="V000131">Mr. Veasey</cosponsor>, <cosponsor name-id="C001125">Mr. Carter of Louisiana</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="M001229">Mrs. McIver</cosponsor>, <cosponsor name-id="W000822">Mrs. Watson Coleman</cosponsor>, <cosponsor name-id="S000344">Mr. Sherman</cosponsor>, <cosponsor name-id="K000402">Mr. Kennedy of New York</cosponsor>, <cosponsor name-id="T000481">Ms. Tlaib</cosponsor>, <cosponsor name-id="D000530">Mr. Deluzio</cosponsor>, <cosponsor name-id="G000599">Mr. Goldman of New York</cosponsor>, and <cosponsor name-id="U000040">Ms. Underwood</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to establish certain labeling requirements for caffeine, and for other purposes.</official-title></form><legis-body id="H7AF8B7BE29AA476A94E8ED2994013EB9" style="OLC"> 
<section id="HA1EFD9AE81D84E3E9266452EA29E2A49" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Sarah Katz Caffeine Safety Act</short-title></quote>. </text></section> <section id="HB2B07FD9C1C9462EAD68803AE44ABEF3"><enum>2.</enum><header>Caffeine labeling requirements</header> <subsection id="HBA3D97BFACBD4119A372E65173A9B3CD"><enum>(a)</enum><header>Information required To be disclosed by restaurants and retail food establishments</header> <paragraph id="HA7074E54AB22489F967307A029B90A6F"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Section 403(q)(5)(H) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/343">21 U.S.C. 343(q)(5)(H)</external-xref>) is amended—</text> 
<subparagraph id="H425E86769B0445E1BDD3AFD23A83A8F6"><enum>(A)</enum><text>by amending subclause (i) to read as follows:</text> <quoted-block style="OLC" id="H1D1A70B07ECB4EA8AAC37AC0ECF5ED11" display-inline="no-display-inline"> <clause id="H04C966DFCCB44E6887403FE019AA4AAE" indent="up2"><enum>(i)</enum><header>General requirements for restaurants and similar retail food establishments</header> <subclause id="H5B026A1061D44A179C7776813F7E2231"><enum>(I)</enum><header>Standard menu items</header><text display-inline="yes-display-inline">Except for food described in subclause (vii), in the case of food that is a standard menu item that is offered for sale in a restaurant or similar retail food establishment that is part of a chain with 20 or more locations doing business under the same name (regardless of the type of ownership of the locations) and offering for sale substantially the same menu items, the restaurant or similar retail food establishment shall disclose the information described in subclauses (ii) and (iii).</text></subclause> 
<subclause id="H776734A087314BD5B1558064CE3175D0"><enum>(II)</enum><header>Temporary menu items</header> 
<item id="H430C62E71A644A3CB3A604AC94E586AD"><enum>(aa)</enum><header>In general</header><text>In the case of food that is a temporary menu item that is offered for sale in a restaurant or similar retail food establishment that is part of a chain with 20 or more locations doing business under the same name (regardless of the type of ownership of the locations) and offering for sale substantially the same menu items, the restaurant or similar retail food establishment shall disclose the information described in subclause (ii)(III).</text></item> <item id="H37FC8462926A40EE925D486F95864A5A"><enum>(bb)</enum><header>Temporary menu item defined</header><text display-inline="yes-display-inline">In this item, the term <term>temporary menu item</term> means a food that appears on a menu or menu board for less than a total of 60 days per calendar year. The 60 days includes the total of consecutive and non-consecutive days the item appears on the menu.</text></item></subclause></clause><after-quoted-block>;</after-quoted-block></quoted-block></subparagraph> 
<subparagraph id="H8760AE027FE24C51BBB9ADA55E23B7DA"><enum>(B)</enum><text>in subclause (ii)—</text> <clause id="H3E58171974414A07BE1DDFB8019B8249"><enum>(i)</enum><text>by redesignating items (III) and (IV) as items (IV) and (V), respectively, and moving the margins of such items 2 ems to the right;</text></clause> 
<clause id="H9ABC3C98D77448388D45F074E5F7A896"><enum>(ii)</enum><text>by inserting after item (II) the following:</text> <quoted-block style="OLC" id="HAE83B80A499C4DE5B7D1ED08E97AEF48" display-inline="no-display-inline"> <subclause id="HD7C39F11BBBA4261AD4AAE8E865292B8" indent="up2"><enum>(III)</enum><text display-inline="yes-display-inline">in the case of a standard menu item or temporary menu item that contains any added caffeine (as the Secretary shall by regulation define) and at least 150 milligrams of total caffeine per serving, the statement ‘High caffeine’, or such other similar statement or symbol as the Secretary determines appropriate, adjacent to the name of the standard menu item or temporary menu item, so as to be clearly associated with such menu item, on the menu listing the item for sale and on the menu board, including a drive through menu board;</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></clause> 
<clause id="H7D7ACCE8D4D14016AC92895FC475AC8A" commented="no"><enum>(iii)</enum><text>in item (IV) (as so redesignated), by inserting before the semicolon the following: <quote>and the number of milligrams of caffeine in the item</quote>; and</text></clause></subparagraph> <subparagraph id="H487C41DD362E49CBA9AF744B80120825"><enum>(C)</enum><text>in subclause (vii)(I), by striking <quote>Subclauses (i) through (vi)</quote> and inserting <quote>Subject to subclause (i)(II), subclauses (i) through (vi)</quote>.</text></subparagraph></paragraph> 
<paragraph id="H593EFE647FE744799F322827A02F9B5E"><enum>(2)</enum><header>Conforming amendments</header><text>Section 403(q)(5) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/343">21 U.S.C. 343(q)(5)</external-xref>) is amended—</text> <subparagraph id="HFEBD2D0A992A448BACD89CD65BA1A822"><enum>(A)</enum><text>in clause (A)—</text> 
<clause id="H40545E8B3D574D4E847632573E0E1CB0"><enum>(i)</enum><text>in subclause (i), by striking <quote>clause (H)(ii)(III)</quote> and inserting <quote>clause (H)(ii)(IV)</quote>; and</text></clause> <clause id="HAC496DECD72B482A9E96CF1490191C8F"><enum>(ii)</enum><text>in subclause (ii), by striking <quote>clause (H)(ii)(III)</quote> and inserting <quote>clause (H)(ii)(IV)</quote>; and</text></clause></subparagraph> 
<subparagraph id="H1A9F57A7D3CC479485608D4F4D237A7C"><enum>(B)</enum><text>in clause (H)—</text> <clause id="H76CEEB2AEE6243A99771C3FD12089E79"><enum>(i)</enum><text>in subclause (ii)(V) (as redesignated by subsection (a)(1)(B)(i) of this section), by striking <quote>item (III)</quote> and inserting <quote>item (IV)</quote>;</text></clause> 
<clause id="H02BFFEFFF080472981FA493310E90A02"><enum>(ii)</enum><text>in subclause (vi), by striking <quote>subclause (ii)(III)</quote> each place it appears and inserting <quote>subclause (ii)(IV)</quote>; and</text></clause> <clause id="H54C0E06B19B347BE990E8F8A9D782A2C"><enum>(iii)</enum><text>in subclause (vii)(II), by striking <quote>subclauses (ii)(III) and (vi)</quote> and inserting <quote>subclauses (ii)(IV) and (vi)</quote>.</text></clause></subparagraph></paragraph></subsection> 
<subsection id="HED5B869F5F5E4B4A983989154BD67BB7"><enum>(b)</enum><header>Caffeine labeling requirements for food and dietary supplements</header><text>Section 403 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/343">21 U.S.C. 343</external-xref>) is amended by adding at the end the following:</text> <quoted-block style="OLC" id="H089AA7018EDC46BCA498BB2D9D9095C9" display-inline="no-display-inline"> <subsection id="HBEAC7ABB923144C6A6D6E0B9E6FCC002"><enum>(z)</enum><text display-inline="yes-display-inline">If it is a food (including a dietary supplement) that contains more than 10 milligrams of caffeine, unless the label of such food includes—</text> 
<paragraph id="HE086B1818FB54A1984AA06968F814551"><enum>(1)</enum><text display-inline="yes-display-inline">the number of milligrams of caffeine in the food;</text></paragraph> <paragraph id="H1C8886F6F3E74E3AB7694083D3810AD0"><enum>(2)</enum><text>a statement of whether the caffeine in the food is naturally occurring or an additive; and</text></paragraph> 
<paragraph id="H7EB44576BAC440FCB2123AE13280ABC5"><enum>(3)</enum><text display-inline="yes-display-inline">an advisory statement indicating that the daily recommended limit of caffeine for healthy adults is 400 milligrams (or such other limit as the Secretary determines appropriate).</text></paragraph></subsection><after-quoted-block>. </after-quoted-block></quoted-block></subsection></section> <section id="HC61C26E3F83148D08771849170DD3D4B" commented="no"><enum>3.</enum><header>FDA and NIH reviews of safety of caffeine</header> <subsection id="H9B0452A095F646E4B36CBEB8B628FFD2" commented="no"><enum>(a)</enum><header>FDA review of caffeine as GRAS</header> <paragraph id="H4A57CE9B2C284D6E984C4E2016CD9C08" commented="no"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, (in this subsection referred to as the <quote>Commissioner</quote>) shall conduct a review of the safety of caffeine and other stimulants, as the Commissioner determines appropriate, in food (including beverages) and dietary supplements.</text></paragraph> 
<paragraph id="H4B76D84010834454B01E61842790CBD0" commented="no"><enum>(2)</enum><header>Elements</header><text display-inline="yes-display-inline">In conducting the review under paragraph (1), the Commissioner shall consider the following:</text> <subparagraph id="HD65F39BBFCA44FA1AF79D36F989AFA24" commented="no"><enum>(A)</enum><text display-inline="yes-display-inline">Whether caffeine should be considered to be generally recognized to be safe, with respect to consumption by healthy populations, under section 201(s) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(s)</external-xref>).</text></subparagraph> 
<subparagraph id="H45A4BDCA76FF4A89B01F30BCCD17447E" commented="no"><enum>(B)</enum><text>The safety of added caffeine or other stimulants, or a complex blend containing a combination of caffeine and other stimulants, in food and dietary supplements.</text></subparagraph> <subparagraph id="H0B7CA3E411DD4AD5B3A099CF2AC096AF" commented="no"><enum>(C)</enum><text>The safety of guarana, taurine, and similar substances in food and dietary supplements with added caffeine.</text></subparagraph> 
<subparagraph id="HA2ED1CCCB4244FE5AE7BF680188103F7" commented="no"><enum>(D)</enum><text>Thresholds for the amount of caffeine, or the amount of a complex blend containing a combination of caffeine and other stimulants, that should be generally recognized as safe when included in food or dietary supplements.</text></subparagraph> <subparagraph id="H8A03AAFFC1A14A7A97A5AE234E04C273" commented="no"><enum>(E)</enum><text display-inline="yes-display-inline">Whether any regulations relating to caffeine in food and dietary supplements should be issued or updated.</text></subparagraph></paragraph> 
<paragraph id="HAC3D08F74A0A4FD189FE53610274890D" commented="no"><enum>(3)</enum><header>Report</header><text>Not later than 6 months after the date of enactment of this Act, the Commissioner shall submit to Congress and make publicly available a report detailing the results of the review under paragraph (1).</text> </paragraph> <paragraph id="H6B1C655D7D15411CA99B8DF373E9FBD2" commented="no"><enum>(4)</enum><header>Consideration of results</header><text display-inline="yes-display-inline">Following the completion of the review under paragraph (1), the Secretary of Health and Human Services—</text> 
<subparagraph id="H034C5A59099F465E8C7A4B4B437BC999" commented="no"><enum>(A)</enum><text>shall, in considering the results of such review, make a determination regarding whether caffeine is generally recognized to be safe, with respect to consumption by healthy populations, under section 201(s) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(s)</external-xref>); and</text></subparagraph> <subparagraph id="H80EBC0041F3F48BB88FCF0CE242B3C86" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">may consider the results of such review in making a determination pursuant to paragraph (q)(5)(H)(ii)(III) or (z)(3) of section 403 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/343">21 U.S.C. 343</external-xref>) (as inserted by subsection (a)(1)(B)(ii), and added by subsection (b), of section 2 of this Act).</text></subparagraph></paragraph></subsection> 
<subsection id="H58A6F8AF360D4C0880122B776AB26EB3" commented="no"><enum>(b)</enum><header>NIH review of caffeine in vulnerable populations</header> 
<paragraph id="H0323ACF0520D4A4F8B82E1FFA2EB2588" commented="no"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, (in this subsection referred to as the <quote>Director</quote>) shall conduct or support a review of the effect of the consumption of caffeine and other stimulants, as the Director determines appropriate, on the vulnerable populations described in paragraph (2). The Director may enter into a contract with an appropriate entity under which such entity will conduct such review.</text></paragraph> <paragraph id="HCD6B958E63F449C0A5C3313BA840A5F6" commented="no"><enum>(2)</enum><header>Vulnerable populations</header><text>The <quote>vulnerable populations</quote> described in this paragraph are the following:</text> 
<subparagraph id="H5171EDF1A1C34FCDA7C4C036086368C2" commented="no"><enum>(A)</enum><text>Children and adolescents.</text></subparagraph> <subparagraph id="HC72169BD61AB48C3B8CF53DC0AEFC420" commented="no"><enum>(B)</enum><text>Individuals with underlying heart conditions.</text></subparagraph> 
<subparagraph id="HEBA75C6005A24816AB0A27AA7E9D7983" commented="no"><enum>(C)</enum><text>Pregnant and breast-feeding women.</text></subparagraph> <subparagraph id="HC300896516EE414EB96DEDB77A7144C9" commented="no"><enum>(D)</enum><text>Individuals with seizure disorders.</text></subparagraph> 
<subparagraph id="H2F4AF350FFE847859890B5D93FA0D908" commented="no"><enum>(E)</enum><text>Individuals with mental health conditions that may be worsened by stimulants.</text></subparagraph> <subparagraph id="HCDEBD28856A44A18BE17E9DEF87B2EF9" commented="no"><enum>(F)</enum><text>Caffeine-sensitive individuals.</text></subparagraph> 
<subparagraph id="H888E2FB0C5D5409E895EFF87C108E645"><enum>(G)</enum><text>Such other individuals as the Director determines appropriate.</text> </subparagraph> </paragraph> <paragraph id="H596BBA5025B1448E8080852E015AD675" commented="no"><enum>(3)</enum><header>Report</header><text>Not later than 6 months after the date of enactment of this Act, the Director shall submit to Congress and make publicly available a report detailing the results of the review under paragraph (1).</text> </paragraph></subsection> 
<subsection id="H29E1F57861E842A29225520828D4844C" commented="no"><enum>(c)</enum><header>Authorization of appropriations</header><text>There is authorized to be appropriated—</text> <paragraph id="H56D9F459B1454AF88D20B00D94EAF3BD" commented="no"><enum>(1)</enum><text>$1,000,000 for the purpose of carrying out subsection (a); and</text></paragraph> 
<paragraph id="H2BF77871947C4FA6843DFA21734B6714" commented="no"><enum>(2)</enum><text>$1,000,000 for the purpose of carrying out subsection (b).</text></paragraph></subsection></section> <section id="HADC57EEE7C3B41948649BAF3B6F6F289"><enum>4.</enum><header>Public education campaign on caffeine safety</header><text display-inline="no-display-inline">The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, in consultation with the Director of the Centers for Disease Control and Prevention, and working with consumer advocacy and patient groups, shall conduct a public education campaign on the safe consumption of caffeine and caffeinated food (including beverages) and dietary supplements. Such campaign shall pay special attention to the following:</text> 
<paragraph id="H310DF6A05425432EBFEDB8A1BBAAFCE6"><enum>(1)</enum><text display-inline="yes-display-inline">The dangers of the overconsumption of caffeine.</text></paragraph> <paragraph id="H8CEA54653C2D43199098451779104946"><enum>(2)</enum><text>The health impacts caffeine can have on certain vulnerable populations, including—</text> 
<subparagraph id="HE245C57940E74BFF8428B5420E74BD2D"><enum>(A)</enum><text display-inline="yes-display-inline">children and adolescents;</text></subparagraph> <subparagraph id="H350627FED384445882988318086EECB8"><enum>(B)</enum><text>individuals with underlying heart conditions;</text></subparagraph> 
<subparagraph id="HAB6ACA336BDE41FEA9EBC554A20D372D"><enum>(C)</enum><text>pregnant and breast-feeding women;</text></subparagraph> <subparagraph id="H3229825002624B239E058C479AC91EA3"><enum>(D)</enum><text>individuals with seizure disorders;</text></subparagraph> 
<subparagraph id="H6D8D3248F4FA43859781D29026B6AAA3"><enum>(E)</enum><text>individuals with mental health conditions that may be worsened by stimulants; and</text></subparagraph> <subparagraph id="H408F259668744C5BABDB84DC1F50FEA8"><enum>(F)</enum><text>caffeine-sensitive individuals.</text></subparagraph></paragraph> 
<paragraph id="H009BB5F3036B45E8A6692FAF2530E1AD"><enum>(3)</enum><text>How caffeine is marketed to children and adolescents.</text></paragraph> <paragraph id="HB9A4065F893A458B87328A1DCA5AD689"><enum>(4)</enum><text>How guarana, taurine, and similar substances impact safety.</text></paragraph> 
<paragraph id="H1DB41B8E7ADD49DBBCDD2421159098BD"><enum>(5)</enum><text>How to safely consume caffeine.</text></paragraph></section> <section id="HB9EE4BDCA05F43AE9875FB3D9EF1AE5C"><enum>5.</enum><header>GAO study and report on marketing of caffeinated beverages</header> <subsection id="HD1864B3C3B444B60A684F1798FCC9FC9"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Comptroller General of the United States shall conduct a study on the marketing of caffeinated beverages in restaurants, in stores, and online (including on social media and by social media influencers). In conducting such study, the Comptroller General shall focus on—</text> 
<paragraph id="H7C35AD2048924C3EA1A28857F598A8CF"><enum>(1)</enum><text>ways in which the marketing of caffeinated beverages (including to children and adults) may be misleading; and</text></paragraph> <paragraph id="HCC984128FE814A998DFDE5FA977A72AC"><enum>(2)</enum><text>how the marketing of such caffeinated beverages is targeted at children and teens.</text></paragraph></subsection> 
<subsection id="H7E69738AC35746E8960242B4B3ABD285"><enum>(b)</enum><header>Report</header><text>Not later than 180 days after the date of enactment of this Act, the Comptroller General of the United States shall submit to Congress a report describing the results of the study conducted under subsection (a), including any recommendations for legislative or administrative action to address the misleading marketing of caffeinated beverages or the targeted marketing of such beverages to children and teens.</text></subsection></section> </legis-body></bill>

